Table 2.
Mutations and LOH of Fas Gene in Malignant Melanomas
Case No. | LOH analysis | Codon | Mutation site | Nucleotide change | Predictive effect | |||
---|---|---|---|---|---|---|---|---|
PA | PB | 3 | 7 | |||||
5 | NI | LOH | NI | NI | 241 | Exon 9 | 963 G to A | Ala → Thr |
9 | – | NI | NI | NI | 250 | Exon 9 | 991 A to G | Asn → Ser |
20 | NI | NI | NI | NI | 251 | Exon 9 | 993 G to A | Val → Ile |
11* | LOH | – | NI | NI | ||||
12* | LOH | NI | NI | NI | ||||
16* | LOH | NI | NI | NI | ||||
24* | LOH | NI | NI | NI | ||||
25* | LOH | NI | NI | NI | ||||
28* | LOH | LOH | NI | NI | ||||
29* | – | LOH | NI | NI | ||||
36* | LOH | – | NI | NI | ||||
37* | NI | NI | LOH | – | ||||
39* | LOH | – | NI | NI |
LOH, loss of heterozygosity; NI, not informative.
*Cases with LOH and without somatic mutation of Fas.